CE-25PA1012X - Updates to Pharmacotherapy for HIV Treatment
Human immunodeficiency virus (HIV) is a chronic viral infection that targets the immune system and requires lifelong antiretroviral therapy. This continuing pharmacy education activity reviews current updates in HIV pharmacotherapy, including mechanisms of action of antiretroviral agents, clinically significant drug–drug interactions, and emerging therapies in the treatment pipeline. The program is designed to support healthcare professionals in optimizing HIV treatment and improving patient outcomes.
Course Outline
Speaker and Disclosure
Speaker
Marisa Brizzi, PharmD, AAHIVP
HIV/Pain Stewardship Clinical Pharmacist
UC Health University of Cincinnati Medical Center
Adjunct Associate Professor, James L. Winkle College of Pharmacy
Disclosure
Dr. Brizzi is Advisor/Consultant for ViiV, Gilead and Merck. She also serves on Speaker's Bureau for ViiV and Gilead.
The planning committee members have no relevant financial relationships with ineligible companies to disclose.
All relevant financial relationships have been mitigated.
Learner Outcomes
Pharmacists who complete the course can expect the following learning outcomes:
- Name mechanisms of action of antiretroviral therapy (ART).
- Identify clinically significant drug interactions with ART.
- List pipeline agents for HIV treatment.
Who Should Register?
This course is designed for pharmacists who want to stay current on evidence-based, patient-centered approaches to managing HIV.
Additional Information
Requirements:
Credit requirements must be completed before the expiration date of the activity. Participants must watch the video in its entirety, complete all evaluations and complete a post-test with a score of 80% or higher. In addition, participants must complete all the steps found in the "Complete Credit Requirements" link provided by the LecturePanda registration confirmation email. After following the link, these steps will include: reviewing the course learning materials, confirming information provided on registration, claiming participation in applicable credits and completing all listed evaluations and quizzes. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted credit will be viewable in your CPE Monitor profile within 24 hours. It is the participants’ responsibility to ensure credit is properly populating on their individual NABP eProfile account. Please contact the James L. Winkle College of Pharmacy Continuing Pharmacy Education Office at (513) 558-4716 or RxCPD@uc.edu with questions or concerns.
The Office of Continuing Pharmacy Education has a formal grievance process to address any problems related to this activity or its administration. (Effective January 2008) Comments and/or concerns about this activity should be sent to the University of Cincinnati James L. Winkle College of Pharmacy, 3255 Eden Ave., Cincinnati, OH 45267-0004, Attention: Dr. Karissa Kim. Questions about Continuing Pharmacy Education credit may be forwarded to this address. The CPE Office can be reached at (513) 558-4716 or via email at RxCPD@UC.edu.
|
Minimum System Requirements
Processor: 1 GHz
Hard Drive: 32 GB
Memory (RAM): 1 GB
Sound card w/speakers
Internet Access: 10 Mbps download
|
Supported Browsers
Latest Chrome Version
Lastest Firefox Version
Lastest Edge Version
Lastest Safari Version
Internet Explorer 11
|
Select a section to register
The University of Cincinnati James L. Winkle College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.